CERS Q4 2021 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$40M+41.4% YoY

Gross Profit

$20M51.1% margin

Operating Income

-$7M-17.5% margin

Net Income

-$9M-22.9% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+10.3%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$237M

Total Liabilities

$152M

Stockholders' Equity

$85M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$28M	+41.4%
Gross Profit	$20M	$16M	+27.3%
Operating Income	-$7M	-$14M	+51.5%
Net Income	-$9M	-$14M	+36.6%

Revenue Segments

Government Contract

$10M100%

Geographic Segments

North America

$24M60%

Europe Middle East And Africa

$16M39%

Other

$417,0001%